Initiation of clozapine therapy in a patient with preexisting leukopenia: A discussion of the rationale of current treatment options

Annals of Clinical Psychiatry

Volumn 13, Issue 4, 2001, Pages 233-237

  Boshes, Roger A ^a   Manschreck, Theo C ^a   Desrosiers, Jean ^a   Candela, Steven ^b   Hanrahan Boshes, Meredith ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b HARVARD UNIVERSITY   (United States)

Author keywords

Autoimmune disorder; Clozapine induced granulocytopenia; Leukopenia; Lithium; Neutropenia

Indexed keywords

CLOZAPINE; FLUPHENAZINE; HALOPERIDOL; LITHIUM; LOXAPINE; OLANZAPINE; PERPHENAZINE; RISPERIDONE; TRIFLUOPERAZINE;

ADULT; ARTICLE; CASE REPORT; COMORBIDITY; DRUG SAFETY; GRANULOCYTOPENIA; HUMAN; IMMUNOPATHOGENESIS; LEUKOPENIA; MALE; PRIORITY JOURNAL; PSYCHOSIS; TREATMENT OUTCOME;

ADULT; AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; CLOZAPINE; HUMANS; LITHIUM; MALE; PRECIPITATING FACTORS;

EID: 0035726949     PISSN: 10401237     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1014681418969     Document Type: Article

References (24)

1. Effects of six months of clozapine treatment on the quality of life of chronic schizophrenic patients
2. Clozapine: A novel antipsychotic drug
3. A re-evaluation of the clinical characteristics of clozapine-induced agranulocytosis in light of the United States' experience
4. Clozapine-induced agranulocytosis: Incidence and risk factors in the United States
5. 51Cr release assay of clozapine-induced cytotoxicity. Evidence for an immunological mechanism
6. N-desmethyl-clozapine: A clozapine metabolite that suppresses haematopoiesis
7. HLAB38, DR4, Dqw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia
8. Leukocytosis during lithium treatment
9. Efficacy of lithium in rheumatoid arthritis with Granulocytopenia (Felty's Syndrome): A preliminary report
10. Agranulocytosis during treatment with clozapine
11. Clozapine-induced agranulocytosis: A situation report up to August 1976
12. Clozapinelithium combined treatment and agranulocytosis
13. Prevention of clozapine-induced neutropenia by pretreatment with lithium
14. Lithium and clozapine-induced neutropenia/agranulocytosis
15. G-CSF (granulocyte colony-stimulating factor) for the management of clozapine-induced agranulocytosis
16. Successful treatment of clozapine-induced agranulocytosis with granulocyte colony stimulating factor
17. Examination of possible toxic and immune mechanisms of clozapine-induced granulocytopenia
18. Combined autoimmune cytopenias
19. Antibodies to myeloid precursor cells in autoimmune neutropenia
20. Immune and idiopathic neutropenia
21. Drug-induced neutropenia
22. Neutrophil antibodies
23. Characterization of elevated neutrophil-associated 1gG in various autoimmune disorders: Not antineutrophil autoantibodies, but possibly immune complexes
24. Use of colony-stimulating factors in the treatment of neutropenia associated with collagen vascular disease